Forte Biosciences (FBRX) Return on Capital Employed Growth (1y) (2018 - 2026)
Forte Biosciences (FBRX) Return on Capital Employed Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,805.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 19,453.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -3,457.00 |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | -5,111.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,111.00 |
| Dec 31, 2025 | 1,720.00 |
| Sep 30, 2025 | 20,553.00 |
| Jun 30, 2025 | 12,293.00 |
| Mar 31, 2025 | 517.00 |
| Dec 31, 2024 | -3,763.00 |
| Sep 30, 2024 | -16,845.00 |
| Jun 30, 2024 | -9,902.00 |
| Mar 31, 2024 | -5,271.00 |
| Dec 31, 2023 | -4,729.00 |
| Sep 30, 2023 | -6,629.00 |
| Jun 30, 2023 | -4,533.00 |
| Mar 31, 2023 | -432.00 |
| Dec 31, 2022 | 1,488.00 |
| Sep 30, 2022 | 1,834.00 |
| Jun 30, 2022 | -395.00 |
| Mar 31, 2022 | 3,937.00 |
| Dec 31, 2021 | 6,721.00 |
| Sep 30, 2021 | 13,872.00 |
| Jun 30, 2021 | 15,633.00 |